Variant report

Variant	esv10458
Chromosome Location	chr6:37616371-37618598
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:205)
CpG islands
(count:674)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:205 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr6:37616225-37616969	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr6:37617520-37618319	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr6:37617857-37617894	K562	blood:	n/a	n/a
4	BHLHE40	chr6:37617776-37618069	HepG2	liver:	n/a	n/a
5	BRCA1	chr6:37616774-37616988	H1-hESC	embryonic stem cell:	n/a	n/a
6	CBX3	chr6:37616208-37616597	K562	blood:	n/a	n/a
7	CHD2	chr6:37616401-37617056	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD2	chr6:37617789-37618235	H1-hESC	embryonic stem cell:	n/a	n/a
9	CREB1	chr6:37616137-37617097	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr6:37617798-37618101	K562	blood:	n/a	n/a
11	CTCF	chr6:37617800-37617950	HEEpiC	esophagus:	n/a	n/a
12	CTCF	chr6:37617760-37617910	GM06990	blood:	n/a	n/a
13	CTCF	chr6:37617760-37618044	GM19239	blood:	n/a	n/a
14	CTCF	chr6:37617800-37617950	GM12868	blood:	n/a	n/a
15	CTCF	chr6:37617780-37617930	HPF	lung:	n/a	n/a
16	CTCF	chr6:37617807-37618006	GM20000	blood:	n/a	n/a
17	CTCF	chr6:37617796-37618023	GM12878	blood:	n/a	n/a
18	CTCF	chr6:37617840-37617990	GM12878	blood:	n/a	n/a
19	CTCF	chr6:37617840-37617990	HUVEC	blood vessel:	n/a	n/a
20	CTCF	chr6:37618200-37618350	HRE	kidney:	n/a	n/a
21	CTCF	chr6:37617892-37617939	MCF-7	breast:	n/a	n/a
22	CTCF	chr6:37617840-37617990	HA-sp	spinal cord:	n/a	n/a
23	CTCF	chr6:37618109-37618347	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTCF	chr6:37617881-37617916	GM10248	blood:	n/a	n/a
25	CTCF	chr6:37617840-37617990	HBMEC	blood vessel:	n/a	n/a
26	CTCF	chr6:37616720-37616870	SAEC	small airway:	n/a	n/a
27	CTCF	chr6:37617840-37617990	GM12866	blood:	n/a	n/a
28	CTCF	chr6:37617860-37618010	RPTEC	kidney:	n/a	n/a
29	CTCF	chr6:37617820-37617970	WERI-Rb-1	eye:	n/a	n/a
30	CTCF	chr6:37618061-37618062	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTCF	chr6:37617820-37617970	GM12869	blood:	n/a	n/a
32	CTCF	chr6:37617800-37617950	GM12871	blood:	n/a	n/a
33	CTCF	chr6:37617880-37618030	GM12864	blood:	n/a	n/a
34	CTCF	chr6:37617740-37617890	HMEC	breast:	n/a	n/a
35	CTCF	chr6:37617820-37617970	GM12867	blood:	n/a	n/a
36	CTCF	chr6:37617798-37618018	GM19240	blood:	n/a	n/a
37	CTCF	chr6:37617766-37618059	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr6:37617828-37618000	GM10266	blood:	n/a	n/a
39	CTCF	chr6:37617856-37617977	Lung_OC	lung:	n/a	n/a
40	CTCF	chr6:37617860-37618010	AG04449	skin:	n/a	n/a
41	CTCF	chr6:37617840-37617990	GM12865	blood:	n/a	n/a
42	CTCF	chr6:37617840-37617990	HRPEpiC	eye:	n/a	n/a
43	CTCF	chr6:37617780-37617930	GM06990	blood:	n/a	n/a
44	CTCF	chr6:37617726-37618418	H1-hESC	embryonic stem cell:	n/a	n/a
45	CTCF	chr6:37617840-37617990	GM12873	blood:	n/a	n/a
46	CTCF	chr6:37616900-37617050	HMEC	breast:	n/a	n/a
47	CTCF	chr6:37617861-37617960	Spleen_OC	spleen:	n/a	n/a
48	CTCF	chr6:37617733-37618114	HepG2	liver:	n/a	n/a
49	CTCF	chr6:37617820-37617970	GM12872	blood:	n/a	n/a
50	CTCF	chr6:37617739-37618067	GM12878	blood:	n/a	n/a

(count:674 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:37617864-37617914	H1-hESC	embryonic stem cell:	embryo
2	chr6:37618123-37618173	T-47D	breast:	n/a
3	chr6:37616410-37616460	RPTEC	kidney:	n/a
4	chr6:37617864-37617914	H1-hESC	embryonic stem cell:	embryo
5	chr6:37618123-37618173	T-47D	breast:	n/a
6	chr6:37616410-37616460	RPTEC	kidney:	n/a
7	chr6:37617956-37618006	BJ	skin:	n/a
8	chr6:37616598-37616648	GM19239	blood:	n/a
9	chr6:37616598-37616648	NT2-D1	testis:	n/a
10	chr6:37618514-37618564	RPTEC	kidney:	n/a
11	chr6:37617864-37617914	NT2-D1	testis:	n/a
12	chr6:37618514-37618564	T-47D	breast:	n/a
13	chr6:37616803-37616853	Hela-S3	cervix:	n/a
14	chr6:37616803-37616853	HL-60	blood:	n/a
15	chr6:37616598-37616648	AG04449	skin:	fetal
16	chr6:37617956-37618006	GM12891	blood:	n/a
17	chr6:37616410-37616460	HEK293	kidney:	embryo
18	chr6:37617956-37618006	MCF-7	breast:	n/a
19	chr6:37618009-37618059	BJ	skin:	n/a
20	chr6:37618514-37618564	GM19239	blood:	n/a
21	chr6:37618514-37618564	K562	blood:	n/a
22	chr6:37617864-37617914	HIPEpiC	eye:	n/a
23	chr6:37617124-37617174	HEK293	kidney:	embryo
24	chr6:37618123-37618173	BJ	skin:	n/a
25	chr6:37616686-37616736	MCF-7	breast:	n/a
26	chr6:37616686-37616736	HRE	kidney:	n/a
27	chr6:37616686-37616736	HCT-116	colon:	n/a
28	chr6:37616598-37616648	HCT-116	colon:	n/a
29	chr6:37618123-37618173	MCF-7	breast:	n/a
30	chr6:37618009-37618059	HCT-116	colon:	n/a
31	chr6:37616686-37616736	NHBE	bronchial:	n/a
32	chr6:37618123-37618173	HMEC	breast:	n/a
33	chr6:37617124-37617174	HepG2	liver:	n/a
34	chr6:37616482-37616532	HUVEC	blood vessel:	n/a
35	chr6:37618514-37618564	MCF-7	breast:	n/a
36	chr6:37617956-37618006	K562	blood:	n/a
37	chr6:37618514-37618564	SKMC	muscle:	n/a
38	chr6:37618009-37618059	HRPEpiC	eye:	n/a
39	chr6:37616598-37616648	CMK	blood:	n/a
40	chr6:37618009-37618059	HNPCEpiC	eye:	n/a
41	chr6:37616803-37616853	HepG2	liver:	n/a
42	chr6:37618009-37618059	A549	lung:	n/a
43	chr6:37618123-37618173	Hela-S3	cervix:	n/a
44	chr6:37617956-37618006	ProgFib	skin:	n/a
45	chr6:37616482-37616532	SKMC	muscle:	n/a
46	chr6:37616686-37616736	T-47D	breast:	n/a
47	chr6:37618009-37618059	NHBE	bronchial:	n/a
48	chr6:37618009-37618059	PANC-1	pancreas:	n/a
49	chr6:37616686-37616736	SAEC	small airway:	n/a
50	chr6:37618009-37618059	AG09309	skin:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:37618578..37621552-chr6:37642899..37645409,2	K562	blood:
2	chr6:37601234..37603729-chr6:37618295..37621074,2	MCF-7	breast:
3	chr6:37617185..37618953-chr6:37619629..37621239,2	K562	blood:
4	chr6:37618357..37620078-chr6:37641465..37644399,2	K562	blood:

No data

Variant related genes	Relation type
MDGA1	TF binding region
MDGA1	CpG island

Extended variants
information (count: 90 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:90 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs555252615	chr6:37616398-37616399	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs575137860	chr6:37616400-37616401	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs185507687	chr6:37616422-37616423	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
4	rs556157717	chr6:37616443-37616444	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs576237312	chr6:37616445-37616446	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs73413369	chr6:37616446-37616447	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs78228665	chr6:37616448-37616449	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
8	rs527492857	chr6:37616454-37616455	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs188700200	chr6:37616456-37616457	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs560873831	chr6:37616464-37616465	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs529905255	chr6:37616468-37616469	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs149705507	chr6:37616469-37616470	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs9380698	chr6:37616495-37616496	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs145809034	chr6:37616501-37616502	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs552630193	chr6:37616549-37616550	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs55866414	chr6:37616586-37616587	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs112520975	chr6:37616615-37616616	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs370581094	chr6:37616627-37616628	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs180823837	chr6:37616628-37616629	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs565999453	chr6:37616663-37616664	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs535222534	chr6:37616664-37616665	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs113498160	chr6:37616704-37616705	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs568782851	chr6:37616716-37616717	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs376880087	chr6:37616724-37616725	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs3734314	chr6:37616744-37616745	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs556220931	chr6:37616755-37616756	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs576099522	chr6:37616774-37616775	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs544639607	chr6:37616782-37616783	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs558625235	chr6:37616809-37616810	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs572020134	chr6:37616826-37616827	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs142960358	chr6:37616846-37616847	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs560734390	chr6:37616937-37616938	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs529966439	chr6:37616942-37616943	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs374088920	chr6:37617018-37617019	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs543309716	chr6:37617035-37617036	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs373812833	chr6:37617050-37617051	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs111318026	chr6:37617070-37617071	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs552242530	chr6:37617076-37617077	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs116499511	chr6:37617121-37617122	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs375937284	chr6:37617129-37617130	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs536977350	chr6:37617184-37617185	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs192214990	chr6:37617206-37617207	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs548831795	chr6:37617221-37617222	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs35935749	chr6:37617289-37617290	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs568646422	chr6:37617355-37617356	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs370883870	chr6:37617367-37617368	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs546435413	chr6:37617405-37617406	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs537786834	chr6:37617417-37617418	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs551308010	chr6:37617518-37617519	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs708022	chr6:37617519-37617520	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Lung cancer	19153074	CNVD
Ovarian cancer	21720365	CNVD
Melanoma	21693616	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Breast cancer	16397240	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Osteosarcoma	21197465	CNVD
Gastric cancer	24379144	CNVD
Neuroblastoma	18923191	CNVD
abnormal development	18461090	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:224 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:37599200-37621800	Weak transcription	NHLF	lung
2	chr6:37602200-37616600	Weak transcription	Right Atrium	heart
3	chr6:37602800-37616400	Weak transcription	Ovary	ovary
4	chr6:37612600-37619800	Weak transcription	Brain Cingulate Gyrus	brain
5	chr6:37614200-37621800	Weak transcription	Aorta	Aorta
6	chr6:37615400-37616400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr6:37615800-37616400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
8	chr6:37615800-37616600	Bivalent Enhancer	Colonic Mucosa	Colon
9	chr6:37615800-37617400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
10	chr6:37615800-37617400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr6:37616000-37616400	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
12	chr6:37616000-37616400	Enhancers	K562	blood
13	chr6:37616000-37616600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
14	chr6:37616000-37616600	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
15	chr6:37616000-37616600	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
16	chr6:37616000-37616600	Enhancers	Gastric	stomach
17	chr6:37616000-37616800	Enhancers	Primary T helper naive cells from peripheral blood	blood
18	chr6:37616000-37616800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
19	chr6:37616000-37616800	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
20	chr6:37616000-37616800	Bivalent Enhancer	Fetal Thymus	thymus
21	chr6:37616000-37617200	Active TSS	ES-WA7 Cell Line	embryonic stem cell
22	chr6:37616000-37617200	Active TSS	H9 Cell Line	embryonic stem cell
23	chr6:37616000-37617200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
24	chr6:37616000-37617200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
25	chr6:37616000-37617200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr6:37616000-37617400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
27	chr6:37616000-37618000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
28	chr6:37616000-37618200	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
29	chr6:37616000-37618400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
30	chr6:37616200-37616400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
31	chr6:37616200-37616400	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
32	chr6:37616200-37616400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
33	chr6:37616200-37616400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
34	chr6:37616200-37616400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr6:37616200-37616400	Enhancers	Left Ventricle	heart
36	chr6:37616200-37616400	Bivalent/Poised TSS	Right Ventricle	heart
37	chr6:37616200-37616400	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
38	chr6:37616200-37616400	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
39	chr6:37616200-37616400	Flanking Bivalent TSS/Enh	Spleen	Spleen
40	chr6:37616200-37616400	Enhancers	GM12878-XiMat	blood
41	chr6:37616200-37616600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
42	chr6:37616200-37616600	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
43	chr6:37616200-37616600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr6:37616200-37616600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr6:37616200-37616600	Bivalent Enhancer	Esophagus	oesophagus
46	chr6:37616200-37616600	Bivalent Enhancer	Stomach Smooth Muscle	stomach
47	chr6:37616200-37616600	Enhancers	HMEC	breast
48	chr6:37616200-37616800	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
49	chr6:37616200-37616800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
50	chr6:37616200-37616800	Bivalent/Poised TSS	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links